Lyme Nosode Drops

NDC 63083-2128 · Professional Complementary Health Formulas

Generic nameLyme Nosode Drops

Dosage formLIQUID

RouteORAL

Active ingredient(s)ANGELICA ARCHANGELICA ROOT, ANGELICA PUBESCENS ROOT, GAMBIR, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, POTASSIUM CHLORIDE, MANGANESE, YUCCA FILAMENTOSA WHOLE, BOVINE TYPE II COLLAGEN (TRACHEAL CARTILAGE), PHYTOLACCA AMERICANA ROOT, GOLDENSEAL, TOXICODENDRON PUBESCENS LEAF, CAUSTICUM, LATIGLUTENASE, OXALIC ACID, ARNICA MONTANA WHOLE, LATRODECTUS MACTANS, BORRELIA BURGDORFERI, TREPONEMIC SKIN CANKER HUMAN, RICKETTSIA AKARI, BABESIA MICROTI, EHRLICHIA CHAFFEENSIS

Strength2; 2; 8; 12; 12; 3; 6; 12; 2; 5; 8; 10; 2; 3; 8; 4; 3; 12; 6; 12; 3 [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL

Pharmacologic classCalculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Marketing categoryUNAPPROVED HOMEOPATHIC

Packages

63083-2128-2 — 59 mL in 1 BOTTLE, DROPPER (63083-2128-2)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

63083-2087 — Fever Flu Symptom Drops, 63083-2089 — Pain Formula I Drops, 63083-2091 — Pain Formula III Drops, 63083-2092 — Pain Formula IV Drops, 63083-2094 — Ulcer Drops, 63083-2095 — Cellular Oxygenator Drops, 63083-2098 — Anxious Drops, 63083-2115 — Vertigo Syncope Drops, 63083-2122 — Urinary Tract Drops, 63083-2124 — PMS Drops, 63083-2136 — Wet Eczema Drops, 63083-2138 — Dysfunctional Bleeding Drops, 63083-2143 — Endotoxin Terrain Drops, 63083-2148 — Fibrous Breast Drops, 63083-2152 — Sleep Disorder Drops, 63083-2154 — TMJ Drops, 63083-2171 — Difficulty Breathing Drops, 63083-2172 — Restless Leg Drops, 63083-3003 — B-Balance Liquescence, 63083-3004 — Blood Stim Liquescence, +2127 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources